TAK - TAKEDA PHARMACEUTICAL CO LTD
18.22
0.140 0.768%
Share volume: 2,765,644
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$18.08
0.14
0.01%
Summary score
17%
Profitability
18%
Dept financing
15%
Liquidity
40%
Performance
11%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.1%
Return on assets
0.95%
Return on sales
10.37%
Return on invested capital
1.02%
Total debt ratio
57.69%
Debt ratio change over timeo
0%
Current Ratio
1.46%
Quick Ratio
1.13%
Cash Position Ratio
0.36%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.31%
Return on assets
0.82%
Return on sales
12.9%
Return on invested capital
0.18%
Total debt ratio
62.76%
Debt ratio change over timeo
0%
Current Ratio
1.26%
Quick Ratio
0.88%
Cash Position Ratio
0.3%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
0.09%
Return on assets
0.81%
Return on sales
12.81%
Return on invested capital
0.05%
Total debt ratio
62.41%
Debt ratio change over time
0%
Current Ratio
1.51%
Quick Ratio
1.08%
Cash Position Ratio
0.37%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TAK | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 1.1% | 18.71% | 4.67% | -3.65% |
| Return on assets | 0.95% | 3.4% | 3.32% | 3.5% |
| Return on sales | 10.37% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 1.02% | 5.38% | 4.17% | 4.99% |
| Profitability | 21% | 94% | 70% | 73% |
| Total debt ratio | 57.69% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 14% | 20% | 20% | 50% |
| Current Ratio | 1.26% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0.88% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.3% | 0.21% | 0.6% | 1.41% |
| Liquididy | 58% | 53% | 70% | 73% |
| Short-term ratios | TAK | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0.31% | 41.05% | 6.87% | -16.17% |
| Return on assets | 0.82% | 3.67% | 3.13% | 2.71% |
| Return on sales | 12.9% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 0.18% | 9.43% | 5.58% | 6.54% |
| Profitability | 17% | 97% | 61% | 61% |
| Total debt ratio | 62.76% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 16% | 23% | 40% | 25% |
| Current Ratio | 1.26% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0.88% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.3% | 0.21% | 0.6% | 1.41% |
| Liquididy | 32% | 31% | 41% | 75% |